Menu Search
Equities

MoonLake Immunotherapeutics

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MLTXN:MEX

MoonLake Immunotherapeutics

Actions
  • Price (MXN)305.30
  • Today's Change36.14 / 13.43%
  • Shares traded120.00
  • 1 Year change--
  • Beta1.2120
Data delayed at least 20 minutes, as of Jan 15 2026 11:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow in USDView more

In 2024, cash reserves at MoonLake Immunotherapeutics fell by 270.74m. Cash Flow from Financing totalled 51.31m or -- of revenues. In addition the company used 116.59m for operations while cash used for investing totalled 205.60m.
Cash flow per share-3.33
Price/Cash flow per share--
Book value per share4.54
Tangible book value per share4.54
More ▼

Balance sheet in USDView more

MoonLake Immunotherapeutics appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio8.50
Quick ratio--
Total debt/total equity0.2552
Total debt/total capital0.2021
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.